Extens
Extens is a Paris-based private equity firm founded in 2014 by Arnaud Houette and Quentin Jacomet dedicated EXCLUSIVELY to healthcare software companies in France and Western Europe. SIREN 840654818 SAS HQ 250 B Rue du Faubourg Saint-Honore 75008 Paris with 14 staff including 4 partners. Tickets EUR 2-15M for SMEs generating EUR 3-20M revenue with at least 50 percent recurring software revenue and a positive EBITDA. Extens manages around EUR 200M across three vintages (Extens I 2014 ~EUR 30M + Extens II 2018 ~EUR 65M + Extens III 2022 EUR 106M Healthcare Software and Data). Notable exits include Enovacom 2018 to Orange Business Services + Discngine 2022 to Chemical Computing Group + Must Informatique and Teranga both 2024 to Orisha + Horizontal Software January 2026 to Octime Group. First non-France investment Medicore Netherlands October 2024.
Extens is a Paris growth equity firm with 19 active companies and 8 exits.
- ·6 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 8 realized deals: 5 years.
- ·Top sector focus: HealthTech (70% of portfolio).
- ·Fund cadence: ~4Y between vintages · last raise 2022.
Sector breakdown
27 companiesGeography breakdown
2 geographiesKey facts
Recent exits
Extens sold Orthalis to SignalSoft Développement in 2026 after 4 years.
Extens sold Horizontal Software to Octime Group in 2026 after 6 years.
Extens sold Sofia Développement to Corilus in 2026 after 7 years.
Extens sold Teranga to Orisha in 2024 after 6 years.
Coverage notes
3 funds tracked, 27 portfolio companies (19 active · 8 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Extens has raised, with its portfolio companies. Hand-checked from public filings.
Extens IIIGrowth2022€106M7 assets1 exitsGrowth2022 · 4yr€106M71
Unrealized
7 held| Company | Entry |
|---|---|
| Canal Santé HealthTech · France | 2022 |
| Imagine Human Software · France | 2023 |
| Medelse HealthTech · France | 2022 |
| Medicore HealthTech · Netherlands | 2024 |
| Optacare HealthTech · France | 2022 |
| SignalSoft Développement Healthcare · France | 2026 |
| Val Solutions HealthTech · France | 2023 |
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Orthalis HealthTech · France | 2022 | 2026 | Secondary | SignalSoft Développement | – |
Extens IIRealizedGrowth2018€65M11 assets3 exitsGrowth2018 · 8yr€65M113
Unrealized
11 held| Company | Entry |
|---|---|
| BMI System Software · France | 2021 |
| Bow Medical HealthTech · France | 2018 |
| Cegape SaaS · France | 2021 |
| Coptis Software · France | 2021 |
| Hoppen HealthTech · France | 2019 |
| IntecMedia HealthTech · France | 2021 |
| Keenturtle HealthTech · France | 2021 |
| MediReport HealthTech · France | 2020 |
| Sancare Software · France | 2018 |
| Sanilea HealthTech · France | 2019 |
| Ubaq HealthTech · France | 2020 |
Realized
3 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Horizontal Software Software · France | 2020 | 2026 | Trade Sale | Octime Group | – |
| Sofia Développement HealthTech · France | 2019 | 2026 | Trade Sale | Corilus | – |
| Teranga HealthTech · France | 2018 | 2024 | Trade Sale | Orisha | – |
Extens IRealizedGrowth2014€30M1 assets4 exitsGrowth2014 · 12yr€30M14
Unrealized
1 held| Company | Entry |
|---|---|
| Kayentis HealthTech · France | 2015 |
Realized
4 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Discngine Software · France | 2017 | 2022 | Trade Sale | Chemical Computing Group | – |
| Enovacom HealthTech · France | 2014 | 2018 | Trade Sale | Orange Business Services | – |
| Must Informatique HealthTech · France | 2017 | 2024 | Trade Sale | Orisha | – |
| SNAL HealthTech · France | 2017 | 2019 | Secondary | Sofia Developpement | – |
About Extens
Extens is a private equity firm with capital deployed across 2 active fund vehicles and a founding year of 1993, headquartered in Paris. The platform targets majority and significant minority stakes in European mid-cap businesses across software and healthcare, deploying institutional capital from successive flagship vehicles.
Investment thesis
The platform deploys buyout and growth equity capital across software and healthcare businesses in France and selectively across Europe, targeting majority and significant minority equity positions in mid-cap and lower mid-cap European companies. Value-creation framework emphasises operational improvement, working capital optimisation and selective M&A activity, with the partnership culture supporting management teams across multi-year ownership periods.
Recent activity
Recent realised exits include Horizontal Software (software, 2021). The platform tracks 2 fund vehicles, 25 active portfolio companies and 1 realised exit across the strategy's history.
Frequently asked questions
- What investment strategy does Extens focus on?
- Extens focuses on Growth, Buyout strategies in the private equity space.
- How many portfolio companies does Extens have?
- Extens has 19 active portfolio companies and 8 completed exits and 3 funds tracked on GP Intel.
- Where is Extens headquartered?
- Extens is headquartered in Paris, France.
- When was Extens founded?
- Extens was founded in 2014.
- What sectors does Extens invest in?
- Extens invests across Healthcare, Software.
- What are Extens's recent exits?
- Recent realized exits by Extens include: Orthalis (2026) to SignalSoft Développement; Horizontal Software (2026) to Octime Group; Sofia Développement (2026) to Corilus; Teranga (2024) to Orisha; Must Informatique (2024) to Orisha; Discngine (2022) to Chemical Computing Group; SNAL (2019) to Sofia Developpement; Enovacom (2018) to Orange Business Services.
Similar firms
Other private equity firms tracked on GP Intel.
France·€196.0B
France·€57.3B
France·€52.8B
France·€40.8B
France·€33.0B
France·€27.0B
France·€25.0B
France·€13.2B
France·€11.6B
France·€11.2B
France·€9.0B
France·€7.0B